TP53 and thyroid gland carcinoma: Besides MKIs, additional strategies for thyroid cancer treatment are currently being investigated that employ strategies that modulate epigenetic changes in thyroid cancer DNA, restore the transcriptional activity of mutant p53, and block signal transduction downstream of different p53 family members.